USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ANATRACE, INC.
Address:
ANATRACE, INC.
26111 Miles Rd
Cleveland, OH 44128 5933
Phone:
N/A
URL:
N/A
EIN:
341458982
DUNS:
621507438
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $2,335,989.00 27
SBIR Phase II $4,902,968.00 10

Award List:

CHEMICAL SENSING ELECTRODES

Award Year / Program / Phase:
1987 / SBIR / Phase I
Award Amount:
$30,000.00
Agency:
DOC
Principal Investigator:
Dr Barry Watson , Vice President
Abstract:
N/a

GLYCATED HEMOGLOBIN BY AUTOMATED AFFINITY CHROMATOGRAPHY

Award Year / Program / Phase:
1987 / SBIR / Phase I
Award Amount:
$43,000.00
Agency:
HHS
Principal Investigator:
Melvin H Keyes Phd
Abstract:
N/a

COMPOSITE, HOLLOW FIBER MEMBRANE OXYGENATION DEVICE

Award Year / Program / Phase:
1987 / SBIR / Phase I
Award Amount:
$42,000.00
Agency:
HHS
Principal Investigator:
Don N Gray Phd
Abstract:
N/a

CHEMICAL SENSING ELECTRODES

Award Year / Program / Phase:
1988 / SBIR / Phase II
Award Amount:
$167,000.00
Agency:
DOC
Principal Investigator:
Dr Barry Watson , Vice President
Abstract:
The study of ocean processes such as mineral dissolution, ion speciation and redox equilibria as well as effluent and pollution monitoring require accurate and precise measurements of both major and minor chemical constituents. although spectrophotometry and flame photometry have been used for sea… More

HEMOGLOBIN DERIVATIVES AS BLOOD SUBSTITUTES

Award Year / Program / Phase:
1988 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Abstract:
The use of blood and blood products is extremely important in the treatment of many patients in serious or crisis situations. the value of these materials, and particularly whole blood, has served to emphasize the problems in providing them in all appropriate circumstances. the use ofblood requires… More

COMPOSITE, HOLLOW FIBER MEMBRANE OXYGENATION DEVICE

Award Year / Program / Phase:
1989 / SBIR / Phase II
Award Amount:
$461,350.00
Agency:
HHS
Principal Investigator:
Don N Gray Phd
Abstract:
The acceptance of extracorporeal oxygenation devices based on gas transfer through a membrane will depend to a large extent on the availability of simpler, easier to use, safer,and lowercost devices. oxygenators using microporous hollowfibers have come into wider use the last five years. they… More

GLYCATED HEMOGLOBIN BY AUTOMATED AFFINITY CHROMATOGRAPHY

Award Year / Program / Phase:
1989 / SBIR / Phase II
Award Amount:
$453,807.00
Agency:
HHS
Principal Investigator:
Melvin H Keyes Phd
Abstract:
Classical assays for determining blood and urine glucose have limited value for the monitoring of an individual's blood glucose level over time. measurement of glycated hemoglobin (ghb) is already gaining acceptance for management of persons with diabetes mellitus. ghb levels are not only useful for… More

NOVEL DETERGENTS FOR CRYSTALLIZING MEMBRANE PROTEINS

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$49,839.00
Agency:
HHS
Principal Investigator:
Melvin Keyes
Abstract:
N/a

BIOCOMPATIBLE COATING FOR AN URETHRAL CATHETER

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$49,948.00
Agency:
HHS
Principal Investigator:
B Watson
Abstract:
N/a

NEW BIOCOMPATIBLE DIALYSIS MEMBRANES

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$49,000.00
Agency:
HHS
Principal Investigator:
Don N Gray
Abstract:
N/a

IMIDOESTERS AS ANTISICKLING AGENTS

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Albert, David E , Principal Investigator
Abstract:
Generally, oxygen affinity increases after treatment of hemoglobin s (hbs) with covalent antisickling agents, such as imidoester crosslinking reagents. adding inositol hexaphosphate (ihp) during the crosslinking procedure will lower the affinity, protect the 2,3-diphosphoglycerate binding site and… More

NOVEL DETERGENTS FOR CRYSTALLIZING MEMBRANE PROTEINS

Award Year / Program / Phase:
1992 / SBIR / Phase II
Award Amount:
$431,183.00
Agency:
HHS
Principal Investigator:
Melvin Keyes
Abstract:
The understanding of protein function is greatly enhanced bythe availability of three-dimensional structural informationobtained by x-ray crystallography. this is true for membrane as well as water-soluble proteins, but the large, well-ordered three-dimensional crystals required for x-ray analyses… More

BIOCOMPATIBLE COATING FOR AN URETHRAL CATHETER

Award Year / Program / Phase:
1992 / SBIR / Phase II
Award Amount:
$500,000.00
Agency:
HHS
Principal Investigator:
B Watson
Abstract:
It has been estimated that approximately a half-million patients acquire urinary tract infections in acute care hospitals in this country every year. the use of the urinary catheter has been cited as the major cause for such infections, the most numerous of all nosocomial infections. this trend of… More

THROMBORESISTANT MATERIAL FOR EXTRACORPOREAL DEVICES

Award Year / Program / Phase:
1992 / SBIR / Phase I
Award Amount:
$49,943.00
Agency:
HHS
Principal Investigator:
Don N Gray
Abstract:
N/a

NEW BIOCOMPATIBLE DIALYSIS MEMBRANES

Award Year / Program / Phase:
1993 / SBIR / Phase II
Award Amount:
$499,965.00
Agency:
HHS
Principal Investigator:
Don N Gray
Abstract:
End-stage renal failure is treated by an extracorporeal dialysis device. over 250,000 patients worldwide are maintained by such thrice weekly treatments. the evolution of the modern dialyzer has been greatly dependent on advances made in polymeric material science. while the modern dialysis unit has… More

Production of Monoclonal Antibodies Specific to Vivrio Cholerae 01

Award Year / Program / Phase:
1993 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Don N. Gray
Abstract:
PRINCIPAL INVESTIGATOR: Chi, Kefung AWARDEE ORGANIZATION: BioKwitech, Inc. 4204-L Sorrento Valley Boulevard San Diego, CA 92121 TELEPHONE NUMBER: (619) 587-6738 AWARDEE NUMBER: 200-93-0667 Cholera is a very severe epidemic disease caused by cholera toxin (CT) of Vibrio cholerae (V. cholerae). Two… More

Production of Wild-Type Measles Hemagglutinin in hte Yeast

Award Year / Program / Phase:
1993 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Don N. Gray
Abstract:
PRINCIPAL INVESTIGATOR: Nakano, Eileen T. AWARDEE ORGANIZATION: Hawaii Biotechnology group, Inc. 99-193 Aiea Heights Dr. Aiea, HI 96701 TELEPHONE NUMBER: (808) 486-5333 AWARDEE NUMBER: 200-93-0668 The incidence of measles infections in North America has recently increased. Sequence comparison… More

The Development of Moleculary Pure Antibody Reagents to Variant

Award Year / Program / Phase:
1993 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Don N. Gray
Abstract:
PRINCIPAL INVESTIGATOR: Slack, John H. AWARDEE ORGANIZATION: Integrated Biotechnology Corp. 11711 North College Ave., Suite 196 Carmel, IN 46032 TELEPHONE NUMBER: (317) 575-7250 AWARDEE NUMBER: 200-93-0669 Measles virus, a severe acute highly contagious human pathogen, is not only responsible for… More

Porosity Prevention in Prophylactic Membranes

Award Year / Program / Phase:
1993 / SBIR / Phase I
Award Amount:
$49,933.00
Agency:
HHS
Principal Investigator:
Don N. Gray
Abstract:
Latex rubber articles in the form of condoms and gloves are used as barriers against the transmission of infectious diseases. The medical community have identified the use of condoms as an effective means for preventing the transmission of the human immunodeficiency virus (HIV) and other sexually… More

Flagellar Antigen Rapid Test for Detection of Antibodies to Borrelia

Award Year / Program / Phase:
1993 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Don N. Gray
Abstract:
PRINCIPAL INVESTIGATOR: Levin, Andrew E. AWARDEE ORGANIZATION: Immunetics 380 Green Street Cambridge, MA 02139 TELEPHONE NUMBER: (617) 492-5416 AWARDEE NUMBER: 200-93-0666 The research program is aimed at providing a simple and reliable serological test which can be used in clinical laboratories,… More

Development of Antipeptide Antibodies as Immunodiagnostic Probes

Award Year / Program / Phase:
1993 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Don N. Gray
Abstract:
PRINCIPAL INVESTIGATOR: Reynolds, Steven H. AWARDEE ORGANIZATION: Life Sciences, Inc. 2900 72nd Street, North St. Petersburg, FL 33710 TELEPHONE NUMBER: (813) 345-9371 AWARDEE NUMBER: 200-93-0680 Tuberculosis is reemerging as a health threat in the United States. Primary reasons include the… More

Rapid and Sensitive Detection of Tuberculosis by MS/MS in Clinical

Award Year / Program / Phase:
1993 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Don N. Gray
Abstract:
PRINCIPAL INVESTIGATOR: Sonesson, Anders AWARDEE ORGANIZATION: Microbial Insights, Inc. 201 Center Park Dr., Suite 1140 Knoxville, TN 37922 TELEPHONE NUMBER: (615) 966-7356 AWARDEE NUMBER: 200-93-0681 In response to the resurgent epidemic of tuberculosis which has been greatly stimulated by the… More

Species Specific Antisera and Positive and Negative Control of

Award Year / Program / Phase:
1993 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Don N. Gray
Abstract:
PRINCIPAL INVESTIGATOR: Garcia, Jorge L. AWARDEE ORGANIZATION: Berkeley Antibody Company 4131 Lakeside Drive, Suite B Richmond, CA 94806-1965 TELEPHONE NUMBER: (510) 222-4940 AWARDEE NUMBER: 200-93-0609 A number of wildlife species are natural reservoirs for zoonotic disease pathogens in the U. S.… More

Production of Human Glutathione S-Transferase Antibodies

Award Year / Program / Phase:
1993 / SBIR / Phase I
Award Amount:
$499,992.00
Agency:
HHS
Principal Investigator:
David E. Albert
Abstract:
Glutathione S-transferases (GSTs) are a complex multigene family of isozymes considered by many to be the single most important class of enzymes involved in the detoxication of endogenous and xenobiotic electrophilic substances including anticancer drugs. Some of these isozymes are polymorphic and… More

Prevention of Allergic Response to Latex Rubber

Award Year / Program / Phase:
1993 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Melvin H. Keyes
Abstract:
Recently latex allergic hypersensitivity has emerged as a new and unexpected health care problem. Latex rubber is used in many products where tissue contact is possible for both the health care practitioner and the patient. Rates of latex hypersensitivity for hospital physicians and nurses are… More

Online Urea Monitoring During Hemodialysis

Award Year / Program / Phase:
1993 / SBIR / Phase I
Award Amount:
$49,992.00
Agency:
HHS
Principal Investigator:
Barry Watson
Abstract:
N/a

POROSITY PREVENTION IN PROPHYLACTIC MEMBRANES

Award Year / Program / Phase:
1993 / SBIR / Phase I
Award Amount:
$49,933.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

Online Urea Monitoring During Hemodialysis

Award Year / Program / Phase:
1995 / SBIR / Phase II
Award Amount:
$499,719.00
Agency:
HHS
Principal Investigator:
Barry Watson
Abstract:
Often with little knowledge of the per treatment efficiency as related to the individual patients needs, Hemodialysis is prescribed for over 400,000 patients worldwide. A methodology and apparatus are proposed for the quantification of urea removal during treatment. A prototype urea sensor will be… More

Alkyl Phosphocholine and Phosphoethanolamine Detergents

Award Year / Program / Phase:
1995 / SBIR / Phase I
Award Amount:
$96,763.00
Agency:
HHS
Principal Investigator:
Melvin Keyes
Abstract:
The understanding of protein function is greatly enhanced by the availability of three-dimensionalinformation obtained by X-ray crystallography. Unfortunately the large, well-ordered three-dimensionX-ray analyses have been difficult to produce for membrane proteins since they tend more naturally… More

THROMBORESISTANT MATERIAL FOR EXTRACORPOREAL DEVICES

Award Year / Program / Phase:
1996 / SBIR / Phase II
Award Amount:
$749,427.00
Agency:
HHS
Principal Investigator:
Don N Gray
Abstract:
The use of extracorporeal, based therapies continues to grow (dialysis, emo, pherisis, detoxification, etc). in every case the use of extracorporeal circulation requires systemic anticoagulation to prevent thrombosis. heparin has been the standard anticoagulant used and is safe and effective in most… More

Alkyl Phosphocholine and Phosphoethanolamine Detergents

Award Year / Program / Phase:
1998 / SBIR / Phase II
Award Amount:
$748,704.00
Agency:
HHS
Principal Investigator:
Melvin Keyes
Abstract:
The understanding of protein function is greatly enhanced by the availability of three-dimensionalinformation obtained by X-ray crystallography. Unfortunately the large, well-ordered three-dimensionX-ray analyses have been difficult to produce for membrane proteins since they tend more naturally… More

IMPROVED SURFACTANTS FOR CELL CULTURE

Award Year / Program / Phase:
1998 / SBIR / Phase I
Award Amount:
$98,994.00
Agency:
HHS
Principal Investigator:
Keyes, Melvin H
Abstract:
N/a

SYNTHESIS AND CHARACTERIZATION OF AMPHIPATHIC POLYMERS

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$104,390.00
Agency:
HHS
Principal Investigator:
Melvin H. Keyes
Abstract:
Not Available Reveo, Inc. has invented a proprietary low cost pigment technology having the unprecedented quality that it can be designed to be highly reflective at any wavelength in the range of less than 300 nm to more than 3000 nm with a reflective bandwidth in the range of less than 40 nm to… More

Synthesis and Characterization of Amphipatic Polymers

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Melvin H. Keyes
Abstract:
DESCRIPTION: (provided by applicant) Ainphipols are low molecular weight (

Synthesis and Characterization of Amphipatic Polymers

Award Year / Program / Phase:
2001 / SBIR / Phase II
Award Amount:
$391,813.00
Agency:
HHS
Principal Investigator:
Melvin H. Keyes
Abstract:
DESCRIPTION: (provided by applicant) Ainphipols are low molecular weight (

Detergents for Dissociation of Lipid Rafts

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$77,436.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Glycosphingolipids and cholesterol form associations with important signaling proteins, within biological membranes forming what are called "rafts". These rafts are characterized by their insolubility even in the presence of many detergents used in membrane… More

Novel Membrane-Mimetic Media for Brain Derived GPCRs

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$494,826.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The importance of brain-derived G protein-coupled receptors (GPCRs) in mental function and health can hardly be overstated. However, our knowledge of the molecular biophysical basis for how GPCRs bind to their cognate agonists and antagonists to elicit… More